Over 20,000 people join search for new dementia treatments
Volunteers at the BioResource have contributed to a study that aims to speed up the development of much-needed dementia drugs. Our Genes & Cognition cohort will enable scientists in universities and industry to involve healthy individuals in clinical trials to test whether new drugs can slow the decline in various brain functions including memory and delay the onset of dementia.
Optibrium partners with FMC Corporation to transform agrochemical discovery
Optibrium’s AI-powered discovery platform Cerella™ chosen by FMC to accelerate its agrochemical discovery pipeline.
PlaqueTec and the Babraham Institute collaborate on early phase target discovery and development
Campus Innovation Award (CIA)-funded project evaluated lead compounds predicted to bind a pro-inflammatory protein discovered by PlaqueTec
Assessment of the impact of earlier access to disease-modifying treatments with more convenient administration frequency in reducing the socioeconomic burden for multiple sclerosis patients in Europe
The socioeconomic impact of Multiple Sclerosis (MS) extends to various areas of a patient’s life including personal wellbeing and mental health, family life and planning, employment and the lives of caregivers, which is associated with a significant economic and societal burden.
Cream of Cambridge science showcase tomorrow’s innovations at Cambridge Wide Open Day
The Cambridge Wide Open Day event is a unique opportunity for all to find out firsthand about the game-changing scientific advancements and technological innovations happening right here in our city, the UK’s science and tech capital.
Guardtech elevate rapid cleanroom offering as new era of Isopod takes shape
Suffolk-based cleanroom construction experts back up new website with a string of exciting developments for the quick-assembly brand
ArgusEye closes €2.8 million funding to accelerate bioprocessing
Led by Voima Ventures and co-led by existing investor Eir Ventures
ERS Genomics appoints John E Milad as Chief Executive Officer
Dublin, Ireland: ERS Genomics Limited (‘ERS’), the CRISPR licensing company,
Celebrating Research Nurses on International Nurses Day 2024
Each year, on 12 May, International Nurses Day highlights the fantastic work carried out by nurses worldwide. It is an opportunity to demonstrate the remarkable difference that nursing staff make to many lives. Here at the BioResource, our Research Nurses are at the forefront of recruiting volunteers to participate in health research. Find out about what their vital role entails and hear from…
CPFT selected as leading NHS innovation site for national programme
Cambridgeshire and Peterborough NHS Foundation Trust has been selected as one of eight NHS Trusts joining a national innovation support scheme this year to ensure that local healthcare staff and patients can benefit from new technology.
New TV series The Face Doctors spotlights life-changing work
World-class surgeons who undertake life-changing treatment of conditions affecting the face, neck and head at Addenbrooke’s Hospital in Cambridge are the focus of a powerful new television series.
Arecor and Medtronic Diabetes establish collaboration to develop a novel thermostable insulin for implantable pump delivery
Medtronic to fund Arecor’s development of Arestat™ enabled novel, high concentration, thermostable insulin, specifically tailored for use in combination with a next-generation implantable pump
Baby born deaf can hear after breakthrough gene therapy
A baby girl born deaf can hear unaided for the first time, after receiving ground-breaking gene therapy when she was eleven months old at Addenbrooke’s Hospital in Cambridge.
Growing Trust launches search for extra talent
Cambridge University Hospitals NHS Foundation Trust – which has nearly 13,000 employees – is on the search for more talented staff.
Challenges plaguing primary care
An In-depth Conversation with Dr. David Buckley, Trinity Court Surgery
Scaling success: marketing tactics for complex products
As you scale up any business, you know there are huge challenges, especially when your offer is very complex or very new. You have larger, more diverse audiences to connect with. Great marketing can help reach almost all of them, as long as it is done with intelligence and a good core strategy.
CMR Surgical appoints Shlomi Cohen as Chief Financial Officer
CMR Surgical – the global surgical robotics business announces the appointment of Shlomi Cohen as Chief Financial Officer (CFO), effective immediately.
Great cyber security audit offer for your schools or Trust
Are you confident in your school’s cyber security measures? In today’s digital age, safeguarding your school against cyber threats is paramount.
Renowned scientist Lord Winston visits The Epicentre in Haverhill
Renowned scientist and genetics expert Lord Robert Winston, visited the laboratory facilities at The EpiCentre in Haverhill on Thursday 24th April, to see the great steps being taken to bring bio-tech and life science businesses to the West Suffolk Town.
Endomag wins King’s Award For Enterprise In International Trade Category
Cambridge, UK - Endomag, one of the UK's fastest-growing MedTech companies, specialising in devices used for the treatment of breast cancer, has been recognised for its impressive growth in the UK and overseas with a 2024 King's Award for Enterprise.
Broken String Biosciences and the Francis Crick Institute collaborate to advance ALS research
Partnership to expand applications of DNA break-mapping technology and advance understanding of genomic instability in development of the neurodegenerative disease amyotrophic lateral sclerosis
CMR Surgical and Kebomed partner to bring Versius to Denmark, Norway, and Finland
The partnership aims to make surgical robotics more widely accessible across the Nordics, so more patients can benefit from minimally invasive surgery.
Mystery risk factor linked to high rates of kidney cancer, major DNA study finds
Researchers analysing the DNA of people with kidney cancer worldwide have found evidence of an unknown trigger that could explain the longstanding mystery of why some countries* have a higher incidence of the disease.
Over 99% of GP’s reject GMS contract changes, with medics assembling to take industrial action
Following the announcement of the 2024/25 national GP General Medical Services (GMS) contract by the Department of Health and Social Care and NHS England, over 99% of GPs have voted against it.
Gyros Protein Technologies introduces Gyrolab Generic Rodent ADA Kit Reagents to support preclinical immunogenicity assessment
Ready-to-use kit expands range of bioanalysis kits, and enables generic detection of immune complexes in rodent samples